John Conyers: “One of the major contributing factors to the problem of abusive patent litigation is the issuance of ambiguous and poor…”

I have an amendment at the desk. The Acting CHAIR. The Clerk will designate the amendment. The text of the amendment is as follows: An Amendment Offered in Lieu of Amendment No. 2 Printed in Part A of House Report No. 115-363 Offered by…

We should of course remain vigilant about pay-for-delay schemes, whereby branded drug manufacturers pay generic manufacturers to delay the entry of a version of branded drugs as the patent on the branded drug expires.

I am a cosponsor of her legislation with great pride.

Although H.R. 469 has many flaws, I am particularly concerned that the bill's broad and ill-defined requirements would effectively delay and possibly deter civil enforcement agencies from providing general relief in discrimination cases…